• SmartestCrowd
    • No organizations
    • No projects
0
0
Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology - Biogen
3/31/26 at 11:00am
Organization
Biogen.com
41 words
0
Comments
The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts.
You are the first to view
https://investors.biogen.com/news-releases/news-release-details/biogen-acquire-apellis-enhancing-companys-growth-portfolio
Create an account or login to join the discussion